MINNEAPOLIS, MN, US, Aug. 25, 2021 (Globe NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV) (the “Firm”) an rising biomedical system firm centered on the commercialization of impressive healthcare therapeutics for pets is pleased to announce that Ann Zieser, DVM has approved a posture with the Business as its new Senior Complex Veterinarian.
“We are incredibly energized to have Ann sign up for the PetVivo staff and present her extensive veterinary skills to additional the eyesight of PetVivo and support other vets in the therapy of companion animals.” claimed John Lai, Chief Govt Officer of PetVivo Holdings, Inc. “Dr. Zieser provides a wealth of working experience to our workforce as an pro in veterinary medicine and the therapeutic treatment of cats, canines and horses.”
Dr. Zieser started her profession as a companion animal practitioner at Middleton Veterinary Clinic (“MVH”) positioned outside the house Madison, Wisconsin. Thirty-a single many years afterwards she proceeds to get the job done at MVH dealing with companion pet dogs and cats undertaking diagnostics, internal medicine, radiology, medical procedures, dentistry to identify just a few disciplines. Dr. Zieser has more contributed to the veterinary local community as the secretary of the neighborhood Dane County Veterinary Clinical Association. Next quite a few different volunteer positions inside the Wisconsin Veterinary Health care Affiliation, Dr. Zieser elevated her participation by accepting the role as President-Elect of the Wisconsin Veterinary Medical Affiliation. Dr. Zieser has more climbed from local and point out arranged veterinary medication into the national arena as the American Veterinary Health care Association alternate delegate and then delegate for the point out of Wisconsin. Dr. Zieser has a degree in biochemistry from the College of Wisconsin – Madison and a Doctorate in Veterinary Medication from UW-Wisconsin School of Veterinary Medicine.
“I am thrilled to be part of the PetVivo crew and take part in the energy to introduce the therapeutic positive aspects of SPRYNG™ to companion animals suffering from osteoarthritis and other lameness afflictions,” said Dr. Zieser. “I am assured that SPRYNG™ will increase the lives of companion animals, as well as their house owners.”
About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (NASDAQ: PETV) is an rising biomedical machine enterprise at the moment centered on the production, commercialization and licensing of ground breaking clinical equipment and therapeutics for companion animals. The Firm’s tactic is to leverage human therapies for the treatment method of companion animals in a capital and time successful way. A essential part of this method is the accelerated timeline to revenues for veterinary clinical devices, which enter the industry considerably previously than additional stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen items for the cure of animals and individuals. A portfolio of 20-one patents guards the Company’s biomaterials, solutions, output procedures and techniques of use. The Company’s guide solution SPRYNG, a veterinarian-administered, intraarticular injection for the therapy of osteoarthritis in canine and horses, is scheduled for expanded industrial sale afterwards this yr.
John Lai, CEO
PetVivo Holdings, Inc.
E mail: [email protected]
Forward-Wanting professional Statements:
The foregoing content may well consist of “forward-on the lookout statements” inside the indicating of Part 27A of the Securities Act of 1933 and Part 21E of the Securities Exchange Act of 1934, each and every as amended. Ahead-searching statements consist of all statements that do not relate entirely to historic or existing information, like with no limitation the Company’s proposed advancement and business timelines, and can be determined by the use of terms this sort of as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative variations of individuals phrases or other equivalent text. Ahead-looking statements are not assures of long run steps or overall performance. These forward-seeking statements, together with the potential listing of the Company’s frequent stock on Nasdaq, are dependent on info currently accessible the Firm and its recent strategies or anticipations and are subject to a variety of uncertainties and challenges that could appreciably have an effect on existing plans. Dangers about the Company’s organization are explained in depth in the Company’s Annual Report on Sort 10-K for the 12 months ended March 31, 2020 and other periodic and current reports submitted with the Securities and Exchange Commission. The Business is underneath no obligation to, and expressly disclaims any this kind of obligation to, update or alter its ahead-hunting statements, whether as a end result of new facts, upcoming occasions or otherwise.